Way cleared for US Surgical case against Ethicon:
This article was originally published in Clinica
A federal court has overturned Johnson & Johnson subsidiary, Ethicon's second attempt to have US Surgical's patent suit thrown out. The decision leaves USS clear to pursue its case against alleged infringements of three of its patents relating to trocars. The company claims that simple damages could amount to $500 million, based on sales of all Ethicon trocar products sold after 1990 (see Clinica No 744, p 10).